A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 271 participants.
Also called NCT02969655
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 271 participants
- Sponsor
- Registry
-
NCT02969655
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02969655. Randomized; quadruple masking; primary purpose treatment. Start 2016-11-21 (actual); primary completion 2018-07-02 (actual). Results posted on 2019-11-29.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
- Condition
- Anaemia
- Intervention (Drug)
- Daprodustat small
- Intervention (Drug)
- Daprodustat small placebo
- Intervention (Drug)
- Daprodustat large
- Intervention (Drug)
- Daprodustat large placebo
- Intervention (Drug)
- Darbepoetin alfa
- Intervention (Drug)
- Darbepoetin alfa placebo
- Lead sponsor
- GlaxoSmithKline
Record details
- Record id
cardio:ct-nct02969655- Content hash
882834b6d9eefd262c9be3e6a7ed796fd0f8f9234fce5a76c0c1a6694bcc19e9